ClinicalTrials.gg

Program

MWN109

A development code. Also written as “MWN109 1”, “MWN109 2” and “MWN109 3”.

Its studies are mostly in Obesity · Diabetes Mellitus, Type 2, led by Lepu Medical.

Furthest: phase 3, since Aug 18, 202611 company-led studies, 5 open or runningNext primary completion: Mar 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Lepu Medical115 open or runningphase 3since Aug 18, 2026Apr 14, 2025Mar 2027phase 2 · NCT07801820

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 14, 2025First study: phase 1 study in OverweightFirst studyNCT06938269 · 60 planned · Australia
  2. Aug 18, 2026Phase 3 study in OverweightPhase 3 reachedNCT07778693 · 760 planned · China
  3. Aug 24, 20265 phase 2 studiesNCT07791654, NCT07791537, NCT07791524 and 2 more
  4. Aug 24, 20264 phase 1 studiesNCT07787728, NCT07787624, NCT07787611 and 1 more

Ahead

  1. Mar 2027Primary completion: phase 2 study in Diabetes Mellitus, Type 2NCT07801820
  2. Sep 2027Primary completion: phase 3 study in OverweightNCT07778693

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 11 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07804797Overweight · China2Active, not recruitingSep 202671
NCT07801820Diabetes Mellitus, Type 2 · China2RecruitingMar 2027240
NCT07801326Diabetes Mellitus, Type 2 · China1CompletedAug 10, 2026162
NCT07791654Overweight · China2CompletedMar 21, 2026120
NCT07791537Overweight · China2Active, not recruitingOct 2026125
NCT07791524Overweight · China2CompletedJul 9, 2026255
NCT07787728Overweight · China1CompletedDec 16, 202540
NCT07787624Healthy Volunteers · China1CompletedJul 20, 202548
NCT07787611Healthy Volunteers · China1CompletedDec 20, 202598
NCT07778693Overweight · China3Not yet recruitingSep 2027760
NCT06938269Overweight · Australia1RecruitingMar 202660

How it is read

Names in the registry

  • “MWN109 1”, 7 entries
  • “MWN109 2”, 7 entries
  • “MWN109 3”, 6 entries
  • “MWN109 4”, 3 entries
  • “MWN109 tablet”, 3 entries

Codes read as this program: MWN109.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.